SAN DIEGO--(BUSINESS WIRE)--#ALS--Libra Therapeutics, Inc., (“Libra”) a private biotechnology company developing novel disease-modifying therapeutics to restore cellular homeostasis and slow the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback